NCT06088030 2024-01-03Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Recruiting50 enrolled
NCT04695223 2021-01-06Arsenic Trioxide for Structural p53 MutationsShanghai Changzheng HospitalPhase 2 Unknown30 enrolled
NCT00250042 2011-09-20A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail GleevecNew Mexico Cancer Research AlliancePhase 2 Completed6 enrolled